ConductScience.org, home

Paper306328

Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.

Zulman J and 4 others. Clin Exp Immunol, 1978. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus. Papers, record 306328. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/306328

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Levamisole maintains cyclophsophamide-induced remission in murine lupus erythematosus.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.51
iCite
Revised in PubMed
2018-11-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zulman JJ
2Michalski JJ
3McCombs CC
4Greenspan JJ
5Talal NN

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclophosphamideMajor topic
LevamisoleMajor topic
Lupus Erythematosus, SystemicMajor topic
Animals
Antibodies, Antinuclear
Antibody Formation
DNA
Immunoglobulins
Kidney Glomerulus
Male
Mice
Mice, Inbred NZB
Remission, Spontaneous
T-Lymphocytes
Time Factors

Source PubMed

Download CSV of topics

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1791550In vitro reversal of cellular unresponsiveness induced by levamisole.Clin Exp Immunol1976https://conductscience.org/library/papers/791550PubMed
2299957Ribavirin: efficacy in the treatment of murine autoimmune disease.Science1977https://conductscience.org/library/papers/299957PubMed
3870559Effects of neonatal thymectomy and splenectomy on survival and regulation of autoantibody formation in NZB/NZW F1 mice.J Immunol1977https://conductscience.org/library/papers/870559PubMed
4864003Androgenic hormones modulate autoantibody responses and improve survival in murine lupus.J Clin Invest1977https://conductscience.org/library/papers/864003PubMed
51088166Therapeutic trials with levamisole and other agents in NZB/W mice.J Rheumatol1976https://conductscience.org/library/papers/1088166PubMed
64509143Levamisole inhibits and cures a solid malignant tumour and its pulmonary metastases in mice.Nat New Biol1972https://conductscience.org/library/papers/4509143PubMed
74169964Pathogenesis of the glomerulonephritis of NZB/W mice.J Exp Med1968https://conductscience.org/library/papers/4169964PubMed
84168098Immunological studies concerning the nephritis of systemic lupus erythematosus.J Exp Med1967https://conductscience.org/library/papers/4168098PubMed
91222762Characterization of the immunostimulants levamisole and tetramisole.Eur J Cancer (1965)1975https://conductscience.org/library/papers/1222762PubMed
101082545Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.N Engl J Med1976https://conductscience.org/library/papers/1082545PubMed
114276856The pathogenesis of autoimmunity in New Zealand black mice.Curr Top Microbiol Immunol1974https://conductscience.org/library/papers/4276856PubMed
121082352Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.Biomedicine1975https://conductscience.org/library/papers/1082352PubMed
134611431A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis.Arthritis Rheum1974https://conductscience.org/library/papers/4611431PubMed
1455652Immunostimulant therapy with levamisole for rheumatoid arthritis.Lancet1976https://conductscience.org/library/papers/55652PubMed
154466566In vitro stimulation of spleen cell cultures by poly I: poly C and levamisole.Cell Immunol1974https://conductscience.org/library/papers/4466566PubMed
16130137Cyclophosphamide protection in NZB/NZW disease. Mechanisms and therapeutic regimens.Arthritis Rheum1976https://conductscience.org/library/papers/130137PubMed
17132279Cellular interactions in lymphocyte proliferation: effect of syngeneic and xenogeneic macrophages.Cell Immunol1976https://conductscience.org/library/papers/132279PubMed
184857626Application of transformations to normalize the distribution of plaque-forming cells.J Immunol1974https://conductscience.org/library/papers/4857626PubMed
194795224Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.Cancer Res1973https://conductscience.org/library/papers/4795224PubMed
204757871Filter radioimmunoassay for antibodies to reovirus RNA in systemic lupus erythematosus.Arthritis Rheum1973https://conductscience.org/library/papers/4757871PubMed

See all 26 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
6995097The general immunopharmacology of levamisole.Drugs1980https://conductscience.org/library/papers/6995097PubMed
6232853Thiabendazole-induced suppression of renal damage in a murine model of autoimmune disease.Am J Pathol1984https://conductscience.org/library/papers/6232853PubMed
3804379Effects of LS-2616 administration upon the autoimmune disease of (NZB x NZW) F1 hybrid mice.Immunology1986https://conductscience.org/library/papers/3804379PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/306328

GET https://conductscience.org/api/papers/v1/306328/references?page=2